These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9827110)

  • 21. Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness.
    Osei K; Gaillard T; Schuster DP
    Diabetes Care; 1997 Mar; 20(3):396-404. PubMed ID: 9051394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus.
    Hanabusa T; Kubo K; Oki C; Nakano Y; Okai K; Sanke T; Nanjo K
    Diabetes Res Clin Pract; 1992 Jan; 15(1):89-96. PubMed ID: 1541240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-peptide response to meal challenge in nondiabetic and diabetic adults living in Wadena, Minnesota.
    Bushhouse SA; Goetz FC; Jacobs DR; Bender AP; French LR; Oestreich PG; Geisser MS
    Diabetes Care; 1992 Oct; 15(10):1335-47. PubMed ID: 1425099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A study of serum free C-peptide responses to oral glucose load in diabetic patients: with special reference to types of diabetes and methods of treatment.
    Hsieh SD; Akanuma Y; Takaku F
    Tohoku J Exp Med; 1984 Mar; 142(3):249-60. PubMed ID: 6374968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [C-peptide determination in diabetics for the evaluation of insulin requirements].
    Keller U; Pasquel M; Berger W
    Schweiz Med Wochenschr; 1987 Feb; 117(6):187-92. PubMed ID: 3551060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.
    Nagi DK; Mohamed Ali V; Jain SK; Walji S; Yudkin JS
    Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diurnal variation of blood ketone bodies in insulin-dependent diabetes mellitus and noninsulin-dependent diabetes mellitus patients: the relationship to serum C-peptide immunoreactivity and free insulin.
    Ubukata E
    Ann Nutr Metab; 1990; 34(6):333-42. PubMed ID: 2076025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Random C-peptide in the classification of diabetes.
    Berger B; Stenström G; Sundkvist G
    Scand J Clin Lab Invest; 2000 Dec; 60(8):687-93. PubMed ID: 11218151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Classification of diabetes in patients with end-stage renal disease. Validation of clinical criteria according to fasting plasma C-peptide.
    Benhamou PY; Marwah T; Balducci F; Zmirou D; Borgel F; Cordonnier D; Halimi S; Papoz L
    Clin Nephrol; 1992 Nov; 38(5):239-44. PubMed ID: 1451336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-peptide in the classification of diabetes in children and adolescents.
    Ludvigsson J; Carlsson A; Forsander G; Ivarsson S; Kockum I; Lernmark A; Lindblad B; Marcus C; Samuelsson U
    Pediatr Diabetes; 2012 Feb; 13(1):45-50. PubMed ID: 21910810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal myocardial kinetics of 123I-heptadecanoic acid in subjects with impaired glucose tolerance.
    Turpeinen AK; Kuikka JT; Vanninen E; Uusitupa MI
    Diabetologia; 1997 May; 40(5):541-9. PubMed ID: 9165222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with type 2 (non-insulin-dependent) diabetes mellitus.
    Jones IR; Owens DR; Luzio S; Williams S; Hayes TM
    Diabetologia; 1989 Sep; 32(9):668-77. PubMed ID: 2676668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.
    Snehalatha C; Ramachandran A; Satyavani K; Latha E; Viswanathan V
    Diabetes Care; 1998 Jan; 21(1):76-9. PubMed ID: 9538973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance.
    Del Prato S; Matsuda M; Simonson DC; Groop LC; Sheehan P; Leonetti F; Bonadonna RC; DeFronzo RA
    Diabetologia; 1997 Jun; 40(6):687-97. PubMed ID: 9222649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin secretory capacity in Singapore diabetic subjects.
    Thai AC; Yeo PP; Chan L; Wang KW; Lui KF; Cheah JS; Tan BY
    Ann Acad Med Singap; 1985 Apr; 14(2):191-3. PubMed ID: 3898977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical and hormonal (C-peptide and glucagon) profile and liability to ketoacidosis during nutritional rehabilitation in Ethiopian patients with malnutrition-related diabetes mellitus.
    Abdulkadir J; Mengesha B; Welde Gebriel Z; Keen H; Worku Y; Gebre P; Bekele A; Urga K; Taddesse AS
    Diabetologia; 1990 Apr; 33(4):222-7. PubMed ID: 2112100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The C-peptide response to glucagon injections in IDDM and NIDDM patients.
    Poulsen S; Billesbølle P; Kølendorf K; Thorsteinsson B
    Horm Metab Res; 1985 Jan; 17(1):39-40. PubMed ID: 3967844
    [No Abstract]   [Full Text] [Related]  

  • 38. Proinsulin levels predict the development of non-insulin-dependent diabetes mellitus (NIDDM) in Japanese-American men.
    Kahn SE; Leonetti DL; Prigeon RL; Boyko EJ; Bergstom RW; Fujimoto WY
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S63-6. PubMed ID: 8894485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum C-peptide concentrations poorly phenotype type 2 diabetic end-stage renal disease patients.
    Covic AM; Schelling JR; Constantiner M; Iyengar SK; Sedor JR
    Kidney Int; 2000 Oct; 58(4):1742-50. PubMed ID: 11012908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men.
    Chen KW; Boyko EJ; Bergstrom RW; Leonetti DL; Newell-Morris L; Wahl PW; Fujimoto WY
    Diabetes Care; 1995 Jun; 18(6):747-53. PubMed ID: 7555498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.